What is the appropriate workup and management for a patient presenting with scattered non‑blanching petechiae on the abdomen, arms, and legs?

Workup and Management of Scattered Non-Blanching Petechiae

Immediately obtain a complete blood count (CBC) with peripheral blood smear to assess platelet count and rule out thrombocytopenia, as this is the critical first step in determining whether this represents immune thrombocytopenia (ITP), meningococcal disease, or another serious condition. 1

Initial Diagnostic Approach

Essential Laboratory Testing

• CBC with differential and peripheral blood smear is mandatory to identify thrombocytopenia and exclude other cytopenias 1
• HIV and hepatitis C testing should be performed in all patients presenting with suspected ITP, as treatment of underlying infection may alter disease course 1
• Look specifically for abnormalities beyond isolated thrombocytopenia (such as leukocyte abnormalities, lymphadenopathy on exam, or multiple cytopenias), which would necessitate bone marrow examination before confirming ITP diagnosis 1

Clinical Assessment Priorities

For pediatric patients: Assess for fever, as the combination of fever with non-blanching rash raises concern for invasive meningococcal disease, which occurred in only 1% of children presenting with this combination in the post-vaccine era 2

Key physical examination findings to document:

• Distribution pattern (localized vs. generalized) 3
• Presence of mucosal bleeding (oral, nasal, or other sites) 1
• Signs of systemic illness (fever, ill appearance, altered mental status) 2
• Hepatosplenomegaly or lymphadenopathy 1

Management Based on Platelet Count

If Thrombocytopenia is Present (ITP Suspected)

Pediatric patients with isolated skin manifestations (petechiae and bruising only):

• Observation alone is recommended regardless of platelet count 1
• No pharmacologic treatment is needed for mild bleeding limited to skin 1

If significant bleeding develops (mucosal hemorrhage, prolonged epistaxis >15 minutes):

• First-line treatment options include either IVIg (0.8-1 g/kg single dose) or short course of corticosteroids 1
• IVIg is preferred when rapid platelet increase is desired (achieves platelet count >20 × 10⁹/L at 48 hours more reliably than corticosteroids) 1
• Anti-D therapy (single dose) can be used in Rh-positive, non-splenectomized children but is contraindicated if hemoglobin is already decreased from bleeding 1

Adult patients:

• Treatment decisions should be based on bleeding severity and platelet count, not platelet count alone 1
• Spontaneous remissions occur but are less common than in children 1

When Bone Marrow Examination is NOT Needed

• Not required in children or adults with typical ITP features (isolated thrombocytopenia without other CBC abnormalities) 1
• Not needed before corticosteroid therapy or even before splenectomy in patients with typical presentation 1
• Not required in children who fail IVIg therapy 1

When Further Investigation IS Required

Bone marrow examination or additional workup is indicated when:

• Abnormalities in white blood cell count are present 1
• Multiple cytopenias exist 1
• Peripheral smear shows findings inconsistent with isolated ITP 1
• Lymphadenopathy or hepatosplenomegaly is detected 1
• Microcytic anemia beyond what would be expected from chronic blood loss 1

Special Considerations

Well-Appearing Infants Without Fever

• Localized petechiae/purpura (especially bilateral lower extremities) in afebrile, well-appearing infants <8 months typically represents benign etiology such as tourniquet phenomenon 3
• Consider 4-hour observation period; if no progression of signs, likely safe for discharge 3
• Full blood count and coagulation studies were normal in 94% of such cases 3

Febrile Children

• While invasive meningococcal disease is rare (1% incidence) in the post-vaccine era, it remains a critical diagnosis to exclude 2
• Current evidence suggests tailored clinical practice guidelines perform better than broad NICE guidelines for risk stratification 2
• Blood cultures and consideration of parenteral antibiotics based on clinical severity 2

Drug-Induced Causes

• Consider medication history, as certain drugs (including amlodipine and others) can cause petechial rash 4
• Drug-induced petechiae typically resolve within 8 weeks of discontinuation 4

Common Pitfalls to Avoid

• Do not reflexively perform bone marrow biopsy based solely on age or before initiating treatment in typical ITP presentations 1
• Do not treat pediatric patients with isolated skin findings (petechiae/bruising only) regardless of how low the platelet count is 1
• Do not assume all petechiae require extensive workup—clinical context (fever, distribution, associated symptoms) guides investigation intensity 2, 3
• Do not overlook HIV and HCV testing in newly diagnosed ITP, as these secondary causes require different management 1